Systemic Sirolimus Monitoring in Pediatric Pulmonary Vein Stenosis
Pediatric Cardiology · 2026
DOI: 10.1007/s00246-025-04038-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Heather Meluskey und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsy…. Hauptthemen laut MEDLINE: Sirolimus, Stenosis, Pulmonary Vein, Drug Monitoring, MTOR Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Systemic sirolimus (SS) is an mTOR inhibitor used in the management of pediatric intraluminal pulmonary vein stenosis (PVS). SS initiation, monitoring, including patient compliance with toxicity surveillance, and potential adverse events (AE) in PVS patients are under reported. A single-center retrospective cohort study of consecutive patients who were initiated on SS for PVS from January 1, 2020 to December 31, 2024 was performed. Fifty patients with a median age of 7 months (range 2–165) received SS for PVS (median number of stenotic veins; n = 3 (1–4)) for a median duration of 18 months (1–60). The median time to therapeutic level was 9 days [IQR 3, 20] with two never achieving therapeutic values. In patients who received SS for at least 6 months ( n = 39), the median number of blood draws and number of dose adjustments in the first 6 months were 14 [IQR 5, 27] and 3 [1, 7], respectively. Most levels among patients (75%; [IQR 64, 84]) did not require a dose adjustment. Toxicity surveillance compliance increased from 58% [IQR 42, 83] to 79% [IQR 62.5, 92] ( p = 0.22) following transitioning ownership of SS management to a dedicated PVS team. Eighteen percent (9/50) of patients had an AE potentially related to SS; SS was discontinued in three. PVS patients receiving SS have high, but variable rates of therapeutic levels and SS discontinuation due to AEs is uncommon. Compliance with safety labs may improve with ownership by a dedicated monitoring team.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Department of Pharmacy, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Clinical Futures, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Department of Cardiovascular and Thoracic Surgery, Dell School of Medicine at the University of Texas, Austin, TX, USA.
- Division of Cardiothoracic Surgery, The Children's Hospital of Philadelphia and Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. callahanr2@chop.edu.
Zitieren
APA
Meluskey, H., Blowey, B., O'Brien, A. B., O'Byrne, M. L., Rome, J. J., Frank, D. B., Avitabile, C. M., Gupta, M., Tang, J., Butler, K. L., Mavroudis, C. D., Fuller, S., & Callahan, R. (2026). Systemic Sirolimus Monitoring in Pediatric Pulmonary Vein Stenosis. Pediatric Cardiology. https://doi.org/10.1007/s00246-025-04038-6
Vancouver
Meluskey H, Blowey B, O'Brien AB, O'Byrne ML, Rome JJ, Frank DB, et al. Systemic Sirolimus Monitoring in Pediatric Pulmonary Vein Stenosis. Pediatric Cardiology. 2026. doi:10.1007/s00246-025-04038-6
BibTeX
@article{Meluskey2026,
author = {Meluskey, Heather and Blowey, Bridget and O'Brien, Anna B and O'Byrne, Michael L and Rome, Jonathan J and Frank, David B and Avitabile, Catherine M and Gupta, Mudit and Tang, Jessica and Butler, Kimberly L and Mavroudis, Constantine D and Fuller, Stephanie and Callahan, Ryan},
title = {Systemic Sirolimus Monitoring in Pediatric Pulmonary Vein Stenosis},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-025-04038-6}
}
EUVIMED